Insight

Sumanta K. Pal: She has developed what I think should be called the ‘Bergerot QOL Index ‘ for kidney cancer

Photo taken from Sumanta K. Pal/X

Feb 1, 2024, 17:14

Sumanta K. Pal: She has developed what I think should be called the ‘Bergerot QOL Index ‘ for kidney cancer

Sumanta K. Pal, Professor and Vice Chair of Academic Affairs at City of Hope, shared on X/Twitter:

“Flashback to 2017 – the first ASCO meeting I attended with Cristiane Bergerot. Fast forward 7 years later and she is a globally recognized expert in HRQOL on the ASCO GU24 mainstage.

In a project mentored by Tom Powles with collaborators including Elizabeth Plimack, Laurence Albiges, Toni Choueiri, Viraj Master, Sarah Psutka, Brian Rini, et al, she has developed what I think should be called the ‘Bergerot QOL Index (BQI)’ for kidney cancer.

It’s a much-needed effort to ensure our patients are evaluated for QOL using metrics that reflect considerations with contemporary therapy.”

Sumanta K. Pal: She has developed what I think should be called the 'Bergerot QOL Index ' for kidney cancer

Source: Sumanta K. Pal/X

ASCO ASCO GU24 Bergerot QOL Index Brian Rini cancer City of Hope Cristiane Bergerot Elizabeth Plimack kidney cancer Laurence Albiges OncoDaily Oncology quality of life Sarah Psutka Sumanta K. Pal Tom Powles Toni Choueiri Viraj Master

Faster, Flexible and Affordable: Mikhail Groubman on Building a Global Legacy in Clinical Research in an Untapped Market

Invest in Health Policy: A Conversation with Professor Andreas Charalambous

FDA Approves Cosibelimab-ipdl for Treatment of Metastatic or Locally Advanced Cutaneous Squamous Cell Carcinoma

Dolph Lundgren’s Fight for Life: How He Survived Kidney Cancer After 9 Years of Battle

Agenus and Tanner Pharma Partner to Expand Global Access to BOT/BAL

Special Coverage